AVEO Annual Total Long Term Liabilities
$40.74 M
+$26.07 M+177.65%
31 December 2021
Summary:
As of January 28, 2025, AVEO annual total long term liabilities is $40.74 million, with the most recent change of +$26.07 million (+177.65%) on December 31, 2021. During the last 3 years, it has risen by +$3.69 million (+9.97%).AVEO Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVEO Quarterly Long Term Liabilities
$29.96 M
-$6.06 M-16.83%
30 September 2022
Summary:
As of January 28, 2025, AVEO quarterly total long term liabilities is $29.96 million, with the most recent change of -$6.06 million (-16.83%) on September 30, 2022. Over the past year, it has dropped by -$5.51 million (-15.54%).AVEO Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVEO Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +177.7% | -15.5% |
| 3 y3 years | +10.0% | +48.5% |
| 5 y5 years | -30.8% | -56.2% |
AVEO Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -79.2% | -85.1% |
AVEO Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $29.96 M(-16.8%) |
| June 2022 | - | $36.03 M(-12.1%) |
| Mar 2022 | - | $40.97 M(+0.6%) |
| Dec 2021 | $40.74 M(+177.7%) | $40.74 M(+14.8%) |
| Sept 2021 | - | $35.48 M(+0.5%) |
| June 2021 | - | $35.31 M(+0.3%) |
| Mar 2021 | - | $35.22 M(+140.0%) |
| Dec 2020 | $14.67 M(+0.3%) | $14.67 M(-8.9%) |
| Sept 2020 | - | $16.11 M(+179.4%) |
| June 2020 | - | $5.77 M(-39.3%) |
| Mar 2020 | - | $9.50 M(-35.1%) |
| Dec 2019 | $14.64 M(-60.5%) | $14.64 M(-27.4%) |
| Sept 2019 | - | $20.17 M(-4.6%) |
| June 2019 | - | $21.14 M(-19.3%) |
| Mar 2019 | - | $26.19 M(-29.3%) |
| Dec 2018 | $37.05 M(-37.0%) | $37.05 M(-40.6%) |
| Sept 2018 | - | $62.35 M(+29.1%) |
| June 2018 | - | $48.28 M(-21.4%) |
| Mar 2018 | - | $61.43 M(+4.4%) |
| Dec 2017 | $58.84 M(+212.0%) | $58.84 M(-14.0%) |
| Sept 2017 | - | $68.44 M(+46.0%) |
| June 2017 | - | $46.87 M(+169.0%) |
| Mar 2017 | - | $17.42 M(-7.6%) |
| Dec 2016 | $18.86 M(+72.7%) | $18.86 M(-23.9%) |
| Sept 2016 | - | $24.78 M(-9.7%) |
| June 2016 | - | $27.43 M(+173.5%) |
| Mar 2016 | - | $10.03 M(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | $10.92 M(+12.5%) | $10.92 M(+12.3%) |
| Sept 2015 | - | $9.72 M(+21.9%) |
| June 2015 | - | $7.97 M(-9.9%) |
| Mar 2015 | - | $8.85 M(-8.8%) |
| Dec 2014 | $9.70 M(-78.4%) | $9.70 M(-25.8%) |
| Sept 2014 | - | $13.08 M(-46.1%) |
| June 2014 | - | $24.29 M(-21.4%) |
| Mar 2014 | - | $30.89 M(-31.3%) |
| Dec 2013 | $45.00 M(-8.9%) | $45.00 M(-1.3%) |
| Sept 2013 | - | $45.57 M(-2.7%) |
| June 2013 | - | $46.82 M(-4.2%) |
| Mar 2013 | - | $48.89 M(-1.0%) |
| Dec 2012 | $49.40 M(+33.9%) | $49.40 M(+8.2%) |
| Sept 2012 | - | $45.67 M(-0.5%) |
| June 2012 | - | $45.90 M(-1.8%) |
| Mar 2012 | - | $46.73 M(+26.6%) |
| Dec 2011 | $36.90 M(-0.8%) | $36.90 M(-6.7%) |
| Sept 2011 | - | $39.54 M(-0.7%) |
| June 2011 | - | $39.83 M(-8.7%) |
| Mar 2011 | - | $43.64 M(+17.3%) |
| Dec 2010 | $37.19 M(-81.0%) | $37.19 M(-6.1%) |
| Sept 2010 | - | $39.59 M(-9.2%) |
| June 2010 | - | $43.62 M(+30.9%) |
| Mar 2010 | - | $33.32 M(-83.0%) |
| Dec 2009 | $195.83 M(+31.2%) | $195.83 M(-2.5%) |
| Sept 2009 | - | $200.76 M(+34.5%) |
| Dec 2008 | $149.24 M(+2.7%) | $149.24 M |
| Dec 2007 | $145.31 M | - |
FAQ
- What is AVEO Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals annual total long term liabilities year-on-year change?
- What is AVEO Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for AVEO Pharmaceuticals?
- What is AVEO Pharmaceuticals quarterly long term liabilities year-on-year change?
What is AVEO Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of AVEO is $40.74 M
What is the all time high annual total long term liabilities for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high annual total long term liabilities is $195.83 M
What is AVEO Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, AVEO annual total long term liabilities has changed by +$26.07 M (+177.65%)
What is AVEO Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of AVEO is $29.96 M
What is the all time high quarterly long term liabilities for AVEO Pharmaceuticals?
AVEO Pharmaceuticals all-time high quarterly total long term liabilities is $200.76 M
What is AVEO Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, AVEO quarterly total long term liabilities has changed by -$5.51 M (-15.54%)